Nuvectis Pharma, Inc. (NVCT)

Nuvectis Pharma Analyst Ratings

• Total Analysts: 1
• Consensus Rating: Strong Buy
• Price Target: $10.00
• Upside: +12.49%

Ratings History

Filter results

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Joseph Pantginis HC Wainwright & Co.	HC Wainwright & Co.	Strong Buy Maintains $15 → $10	Strong Buy	Maintains	$15 → $10	+12.49%	Aug 4, 2025
Joseph Pantginis HC Wainwright & Co.	HC Wainwright & Co.	Strong Buy Reiterates $11 → $15	Strong Buy	Reiterates	$11 → $15	+68.73%	Apr 30, 2025
Naz Rahman Maxim Group	Maxim Group	Strong Buy Initiates $17	Strong Buy	Initiates	$17	+91.23%	Apr 2, 2025
Yale Jen Laidlaw & Co.	Laidlaw & Co.	Strong Buy Initiates $19	Strong Buy	Initiates	$19	+113.72%	Mar 17, 2025
Joseph Pantginis HC Wainwright & Co.	HC Wainwright & Co.	Strong Buy Maintains $21 → $11	Strong Buy	Maintains	$21 → $11	+23.73%	Feb 25, 2025
Joseph Pantginis HC Wainwright & Co.	HC Wainwright & Co.	Strong Buy Reiterates $21	Strong Buy	Reiterates	$21	+136.22%	Aug 6, 2024
Joseph Pantginis HC Wainwright & Co.	HC Wainwright & Co.	Strong Buy Reiterates $21	Strong Buy	Reiterates	$21	+136.22%	May 8, 2024
Joseph Pantginis HC Wainwright & Co.	HC Wainwright & Co.	Strong Buy Reiterates $21	Strong Buy	Reiterates	$21	+136.22%	Sep 15, 2023
Joseph Pantginis HC Wainwright & Co.	HC Wainwright & Co.	Strong Buy Reiterates $21	Strong Buy	Reiterates	$21	+136.22%	Mar 7, 2023
Joseph Pantginis HC Wainwright & Co.	HC Wainwright & Co.	Strong Buy Reiterates $21	Strong Buy	Reiterates	$21	+136.22%	Feb 10, 2023
Aydin Huseynov Ladenburg Thalmann	Ladenburg Thalmann	Strong Buy Initiates $21	Strong Buy	Initiates	$21	+136.22%	Jul 13, 2022
Joseph Pantginis HC Wainwright & Co.	HC Wainwright & Co.	Strong Buy Maintains $14 → $21	Strong Buy	Maintains	$14 → $21	+136.22%	May 10, 2022
Joseph Pantginis HC Wainwright & Co.	HC Wainwright & Co.	Strong Buy Initiates $14	Strong Buy	Initiates	$14	+57.48%	Mar 2, 2022